NEUROPHET, Inc. (KOSDAQ:380550)
14,650
-430 (-2.85%)
Aug 14, 2025, 2:40 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 168.47 billion as of August 14, 2025.
Market Cap
168.47B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14,650.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 168.47B, a decrease of -27.68%. That is a compound annual growth rate of -99.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 173.06B | -25.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.45T |
Celltrion | 38.14T |
ALTEOGEN | 22.98T |
Yuhan | 8,383.50B |
SK Biopharmaceuticals | 7,737.35B |
PharmaResearch | 7,064.96B |
Peptron | 6,989.21B |
LigaChem Biosciences | 5,419.69B |